Patent · US Active

Selective estrogen receptor degraders

US11117902B2 · kind B2 · utility

2Cited by

3References

16Claims

0Family size

Assignee

ELI LILLY AND COMPANY · US

Inventors

Jolie Anne Bastian · Indianapolis, US
Jeffrey Daniel Cohen · Indianapolis, US
Almudena Rubio · Carmel, US
Daniel Jon Sall · Greenwood, US
Jennifer Anne McMahon · Tampa, US

Key dates

Filing date	May 18, 2020
Grant date	Sep 14, 2021
Priority date	—
Expiry date	May 18, 2040

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K45/06
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Novel selective estrogen receptor degraders (SERDs) according to the formula: pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, wherein either R1 or R2 is independently selected from Cl, F, —CF3, or —CH3, and the other is hydrogen, and methods for their use are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.